CXCL16 and breast carcinoma: Araujo et al. recently reported that OSM derived from tumor-infiltrating myeloid cells reprograms fibroblasts to secrete VEGF and the chemokines CXCL1 and CXCL16, resulting in enhanced myeloid cell recruitment and breast cancer progression (34).